Skip to main content

Boston Scientific Cardiovascular revenue

  • BSX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$44.34+0.32%Close 13 Nov 2026 · Market value $63.59B

Cardiovascular revenue at Boston Scientific came to $3.4B for the quarter to 30 Sep 2026, up 1.9% from a year earlier.

As Boston Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 2 Nov 2026.

By quarter

$2.3BDec 2023$2.4BMar 2024$2.6BJun 2024$2.7BSep 2024$2.9BDec 2024$3.1BMar 2025$3.3BJun 2025$3.3BSep 2025$3.5BDec 2025$3.5BMar 2026$3.6BJun 2026$3.4BSep 2026
Boston Scientific Cardiovascular revenue, every reported period
Period endingCardiovascular revenueChange on a yearFiled
30 Sep 2026$3.4Bup 1.9%2 Nov 2026
30 Jun 2026$3.6Bup 8.3%3 Aug 2026
31 Mar 2026$3.5Bup 13.5%1 May 2026
31 Dec 2025$3.5Bup 18.2%17 Feb 2026
30 Sep 2025$3.3Bup 22.4%3 Nov 2025
30 Jun 2025$3.3Bup 26.8%1 Aug 2025
31 Mar 2025$3.1Bup 26.2%1 May 2025
31 Dec 2024$2.9Bup 28.8%18 Feb 2025
30 Sep 2024$2.7Bup 25.0%1 Nov 2024
30 Jun 2024$2.6Bup 17.8%1 Aug 2024
31 Mar 2024$2.4Bup 15.9%1 May 2024
31 Dec 2023$2.3Bup 14.0%20 Feb 2024
30 Sep 2023$2.2Bup 11.6%1 Nov 2023
30 Jun 2023$2.2Bup 12.2%3 Aug 2023
31 Mar 2023$2.1Bup 12.7%4 May 2023
31 Dec 2022$2.0Bup 6.4%23 Feb 2023
30 Sep 2022$2.0Bup 9.1%3 Nov 2022
30 Jun 2022$2.0Bup 6.0%4 Aug 2022
31 Mar 2022$1.9Bup 11.4%5 May 2022
31 Dec 2021$1.9Bup 85.8%23 Feb 2022
30 Sep 2021$1.8Bup 79.0%4 Nov 2021
30 Jun 2021$1.9Bup 125.8%6 Aug 2021
31 Mar 2021$1.7Bup 63.8%6 May 2021
31 Dec 2020$1.0Bdown 11.9%23 Feb 2021
30 Sep 2020$1.0Bdown 5.3%5 Nov 2020
30 Jun 2020$834.0Mdown 18.7%5 Aug 2020
31 Mar 2020$1.0Bup 5.6%6 May 2020
31 Dec 2019$1.2Bup 18.5%25 Feb 2020
30 Sep 2019$1.1Bup 16.5%5 Nov 2019
30 Jun 2019$1.0Bup 6.3%30 Jul 2019
31 Mar 2019$972.0Mup 4.2%29 Apr 2019
31 Dec 2018$971.0Mup 6.2%19 Feb 2019
30 Sep 2018$908.0Mup 6.0%29 Oct 2018
30 Jun 2018$965.0Mup 10.2%31 Jul 2018
31 Mar 2018$933.0Mup 9.6%1 May 2018
31 Dec 2017$914.0M—20 Feb 2018
30 Sep 2017$857.0Mup 4.4%2 Nov 2017
30 Jun 2017$876.0Mup 4.3%3 Aug 2017
31 Mar 2017$851.0M—3 May 2017
30 Sep 2016$821.0Mup 3.0%3 Nov 2016

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Boston Scientific: Interventional Cardiology & Vascular Therapies revenue · Electrophysiology revenue · Endoscopy revenue · Peripheral Interventions revenue · Urology revenue · Cardiac Rhythm Management revenue · Watchman revenue · Neuromodulation revenue · Interventional Oncology & Embolization revenue · Cardiology revenue · MedSurg revenue · United States revenue · Int'l revenue · Emerging Markets revenue · financial statements

Every KPI and segment of BSX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.